Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis

BACKGROUND: Frontline immune checkpoint inhibitors (ICI)-based regimens in non-oncogene-addicted non-small-cell lung cancer (NSCLC) have been deeply investigated. To rank the available therapeutic options, we carried out a systematic review and Bayesian meta-analysis. METHODS: A comprehensive search...

Descripción completa

Detalles Bibliográficos
Autores principales: Siciliano, M.A., Caridà, G., Ciliberto, D., d’Apolito, M., Pelaia, C., Caracciolo, D., Riillo, C., Correale, P., Galvano, A., Russo, A., Barbieri, V., Tassone, P., Tagliaferri, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271478/
https://www.ncbi.nlm.nih.gov/pubmed/35427835
http://dx.doi.org/10.1016/j.esmoop.2022.100465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271478/
https://www.ncbi.nlm.nih.gov/pubmed/35427835
http://dx.doi.org/10.1016/j.esmoop.2022.100465

Ejemplares similares